Matthew J Barkovich1, Ryan M Nillo1, Chin Hong Tan1, Leo Sugrue1, Anthony James Barkovich1, and Rahul S Desikan1
1Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States
Synopsis
Subcortical volumes were quantitatively
evaluated on clinical MRI exams of neurofibromatosis type 1 (NF1) and tuberous
sclerosis complex (TSC) patients. Robustly larger volumes of several
subcortical structures, including the thalamus, hippocampus and ventral diencephalon,
were found in NF1; characteristic NF1 imaging abnormalities are found in these
areas. In TSC, we found smaller
cerebellar volumes; findings that have been associated with autistic phenotypes.
Cluster analysis reveals three distinct clustering patterns, each corresponding
to a patient class. These
results show the feasibility of obtaining automatic quantitative measurements
of anatomic structures from clinical MRI exams.
Introduction
Neurofibromatosis type 1 (NF1) and tuberous
sclerosis complex (TSC) are both neurocutaneous genetic disorders caused by
mutations of genes in the mTOR/AKT/P13K signaling pathway, a pathway that is critical
to growth1, 2. Both mutated genes (NF1 in
NF1 and TSC1/TSC2 in TSC) normally form proteins that inhibit the mTOR pathway,
therefore both are multisystem disorders with myriad neural manifestations,
ranging from benign hamartomatous overgrowth to neoplasias and neurocognitive
impairment3.
Both diseases have characteristic, clinically apparent imaging
abnormalities. Myelin vacuolization in
NF1 is characteristically seen in the deep
grey nuclei, brainstem, and cerebellar white matter appearing during the first
decade of life and resolving by the second4. Enlargement of the thalami and caudates have also been reported5. TSC patients have
multiple cerebral dysplastic and hamartomatous lesions including cortical
tubers and subependymal nodules6. Decreased cerebellar
cortical volumes are reported in TSC, associated with an autistic phenotype7, 8. We applied established,
automated, morphometric MRI methods to clinical scans of NF1 and TSC patients
performed at our institution to evaluate the volumetric abnormalities in the
subcortical regions affected by these diseases.
Methods
We quantitatively evaluated brain
morphometry using the Freesurfer 6.0 software package9 in 32 clinically diagnosed NF1 patients, 26
clinically diagnosed TSC patients, and 245 age and sex matched normal controls
from the Pediatric Imaging Neurocognition Genetics (PING) study10. We compared ten
intracranial volume (ICV) corrected subcortical regions of interest (ROIs),
chosen a priori based on the
characteristic location of imaging abnormalities, in NF1 and TSC patients, to
controls and generated standard scores (z-scores) for each ICV corrected
subcortical ROI. We then evaluated these differences as a function of age and used
a hierarchical cluster analysis to evaluate the
relationship between subcortical volumes in our three cohorts.Results
Compared to controls, we found NF1 patients to have significantly
larger (Fig. 1) ICV-corrected volumes of the thalamus (β =
1.43, standard error (SE) = 0.16, p-value = 3.38 x 10-16),
hippocampus (β = 1.34, SE = 0.16, p-value = 7.84 x 10-16), amygdala (β
= 0.93, SE = 0.16, p-value = 1.96 x 10-8) and ventral diencephalon (β = 1.63, SE = 0.15, p-value = 9.06 x 10-23).
In TSC we found significantly smaller ICV-corrected volumes of the putamen (β =
-0.54, SE = 0.20, p-value =0.00630), and cerebellar cortex (Fig. 1D) (β = -0.72,
SE = 0.19, p-value =0.000261). Although
the globus pallidi were significantly larger in NF1
patients (p-value = 0.00246), they showed a significant decrease in volume with
respect to age in the NF1 cohort (p-value = 1.39 x 10-7)
(Fig. 2A)Discussion
Both of the examined mTOR pathway disorders have significant
volumetric differences from controls on measurements from clinically obtained
MRI scans (Fig. 1). Building on prior
NF1 morphometry analyses, subcortical volumes are larger in NF1 patients
relative to controls in regions where characteristic myelin vacuolization
occurs (deep grey nuclei). Also,
although our study was not longitudinal, ICV corrected volumes of the globus
pallidi in NF1 patients decreased with age, corresponding to the time course of
myelin vacuolization (Fig 2A), an effect not seen in other structures or regions
of NF1 patients, in TSC patients, or in normal controls. This suggests that
there may be other dynamic effects of the NF1 that are not apparent on T2
weighted imaging.
TSC patients exhibit decreased cerebellar volumes (Fig. 1D)
and volumetric differences in the basal ganglia. Diminished cerebellar volumes
have been reported in TSC8, associated with the autistic
TSC phenotype11.
The cluster analysis (Fig. 3) shows three different patterns
depending on phenotype. In controls the
subcortical regions cluster into known anatomic subdivisions (basal ganglia,
limbic system, medial temporal, etc.), whereas in NF1 regions cluster by magnitude
of their volumetric effect, and in TSC the cerebellum stands apart from the
remaining structures.
Conclusion
NF1 is characterized by robustly larger volumes of several
subcortical structures including the thalamus, hippocampus, and ventral diencephalon,
the same regions where characteristic myelin vacuolization occurs. In contrast,
TSC patients exhibit smaller cerebellar volumes and volumetric changes in the
basal ganglia. These results show the feasibility of obtaining automatic
quantitative measurements of anatomic structures from clinical MRI exams.Acknowledgements
Dr. Matthew J. Barkovich was supported by the National Institutes
of Health (NIBIB) T32 Training Grant, T32EB001631
The UCSD PING study for normative control data.
References
-
Cawthon RM, Weiss R, Xu GF, et al. A major segment of
the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point
mutations. Cell. 1990;62:193-201.
-
Laplante
M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274-293.
-
Payne
JM, Moharir MD, Webster R, North KN. Brain structure and function in
neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry. 2010;81:304-309.
-
Payne
JM, Pickering T, Porter M, et al. Longitudinal assessment of cognition and
T2-hyperintensities in NF1: an 18-year study. Am J Med Genet A. 2014;164A:661-665.
-
Violante
IR, Ribeiro MJ, Silva ED, Castelo-Branco M. Gyrification, cortical and
subcortical morphometry in neurofibromatosis type 1: an uneven profile of
developmental abnormalities. J Neurodev
Disord. 2013;5:3.
-
Sundberg
M, Sahin M. Cerebellar Development and Autism Spectrum Disorder in Tuberous
Sclerosis Complex. J Child Neurol. 2015;30:1954-1962.
-
Weisenfeld
NI, Peters JM, Tsai PT, et al. A magnetic resonance imaging study of cerebellar
volume in tuberous sclerosis complex. Pediatr
Neurol. 2013;48:105-110.
-
Vaughn
J, Hagiwara M, Katz J, et al. MRI characterization and longitudinal study of
focal cerebellar lesions in a young tuberous sclerosis cohort. AJNR Am J Neuroradiol. 2013;34:655-659.
9. Fischl
B. FreeSurfer. Neuroimage. 2012;62:774-781.
- Jernigan
TL, Brown TT, Hagler DJ, Jr., et al. The Pediatric Imaging, Neurocognition, and
Genetics (PING) Data Repository. Neuroimage.
2016;124:1149-1154.
-
Weber AM,
Egelhoff JC, McKellop JM, Franz DN. Autism and the cerebellum: evidence from
tuberous sclerosis. J Autism Dev Disord. 2000;30:511-517.